Sun Fanglin, a leading Chinese scientist and director of the Advanced Institute of Translational Medicine at Tongji University, died on July 10 at age 58. According to an obituary posted by the institute, Sun’s research into cell aging and epigenetics provided a core theoretical framework for new anti-tumour drugs and cell therapies, specifically by discovering biological pathways to reverse drug resistance in tumours.
Reversing Drug Resistance in Cancer Treatment
One of the most significant hurdles in oncology is the ability of tumours to become resistant to targeted drugs. According to Tongji University, Sun Fanglin’s research team was the first in the world to crack this challenge.
By identifying the specific biological pathways that allow cancer cells to evade treatment, Sun’s work enabled the development of methods to reverse this resistance.
Did you know? Epigenetics is the way behaviour and the environment can alter the way genes work.
The Role of Epigenetics and Gene Regulation in Aging
Sun specialized in the intersection of gene regulation and epigenetics. This field examines how behavior and environment alter gene function, which in turn influences how cells age and whether they form tumours.
His work as chief scientist for the National Programme on Key Basic Research focused on these mechanisms.
Translational Medicine: From Lab to Bedside
As the former dean of the School of Life Sciences and Technology and director of the Advanced Institute of Translational Medicine, Sun focused on “translational” science.
The application of his findings on cell aging is now being used to refine cell therapies.
Pro Tip: For those tracking breakthroughs in oncology, look for research mentioning “epigenetic reprogramming.”
Future Trends in Anti-Tumour Drug Development
Frequently Asked Questions
Who was Sun Fanglin?
Sun Fanglin was a prominent Chinese biologist, former dean of the School of Life Sciences and Technology at Tongji University, and a leader in cancer and aging research.
What was his major contribution to cancer research?
According to his institute, his team first discovered biological pathways to reverse the process of tumours becoming resistant to targeted drugs.
What is epigenetics?
Epigenetics is the way behaviour and the environment can alter the way genes work.
Want to stay updated on the latest breakthroughs in medical science? Subscribe to our newsletter or explore our latest coverage on translational medicine.